Cullinan Management (CGEM) Price & Analysis

Compare

312 Followers

CGEM Stock Chart & Stats

$10.94

-$0.28(-2.38%)

At close: Jan 08 4:00 PM EST

$10.94

-$0.28(-2.38%)

Day’s Range― - ―

52-Week Range$5.68 - $13.33

Previous CloseN/A

Volume73.34K

Average Volume (3M)1.02M

Market Cap

$600.21M

Enterprise Value$18.91M

Total Cash (Recent Filing)$332.60M

Total Debt (Recent Filing)$1.19M

Price to Earnings (P/E)―

Beta1.08

Next Earnings

Mar 05, 2026

EPS Estimate

-0.79

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.77

Shares Outstanding59,076,260

10 Day Avg. Volume584,770

30 Day Avg. Volume1,015,684

Financial Highlights & Ratios

PEG Ratio0.25

Price to Book (P/B)1.11

Price to Sales (P/S)0.00

P/FCF Ratio-4.51

Enterprise Value/Market Cap0.03

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit-248.77

Enterprise Value/Ebitda-0.08

Forecast

1Y Price Target

$31.71

Price Target Upside189.85% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering9

EPS Forecast (FY)-3.03

Revenue Forecast (FY)$24.59M

Bulls Say, Bears Say

Bulls Say

Clinical Trial ResultsData demonstrated promising, durable CLN-049 monotherapy activity in a heavily pretreated AML patient population.

Market ReactionCullinan shares closed up 17.5% following the positive results, with shares now up over 100% since early October.

Safety ProfileCLN-049 continues to show a safe and tolerable profile, with nearly all CRS limited to Grade 1/2 and the majority of CRS events occurring after a step-up dose or target dose 1.

Bears Say

Adverse EventsThe most common TRAEs included CRS in 40% of patients, infusion-related reactions in 35%, as well as febrile neutropenia, pneumonia, stomatitis, and WBC decrease in 17.5% each.

Conflict Of InterestInvestors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report.

Cullinan Management News

Cullinan Therapeutics price target raised to $27 from $26 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Cullinan Therapeutics (CGEM) to $27 from $26 and keeps a...

2d ago

CGEM

Cullinan Therapeutics price target raised to $30 from $28 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Cullinan Therapeutics (CGEM) to $30 from $28 and keeps an...

2d ago

CGEM

Cullinan Therapeutics provides corporate update, anticipated 2026 milestones

Cullinan Therapeutics (CGEM) provided a corporate update and shared anticipated business highlights for 2026. Highlights; Data readouts planned...

2d ago

CGEM

Cullinan: Buy Rating Reiterated on 2026 Clinical Catalysts and Undervalued Pipeline Upside

William Blair analyst Matt Phipps has reiterated their bullish stance on CGEM stock, giving a Buy rating today....

1d ago

CGEM

Cullinan Management Outlines Catalyst-Rich 2026 Pipeline Outlook

An announcement from Cullinan Management ( ($CGEM) ) is now available. On January 8, 2026, Cullinan Therapeutics issued...

2d ago

CGEM

Cullinan Therapeutics price target raised to $33 from $22 at Clear Street

Clear Street raised the firm’s price target on Cullinan Therapeutics (CGEM) to $33 from $22 and keeps a...

1M ago

CGEM

Cullinan Therapeutics price target raised to $34 from $25 at Wedbush

Wedbush analyst Robert Driscoll raised the firm’s price target on Cullinan Therapeutics (CGEM) to $34 from $25 and...

1M ago

CGEM

Buy Rating for Cullinan Management Driven by Promising CLN-049 Clinical Data and Strategic Development Plan

Analyst Sean Laaman from Morgan Stanley maintained a Buy rating on Cullinan Management and keeping the price target...

1M ago

CGEM

Promising Outlook for Cullinan Management: Buy Rating Backed by Strong Therapeutic Developments and Financial Position

Soumit Roy, an analyst from JonesTrading, maintained the Buy rating on Cullinan Management. The associated price target remains...

1M ago

CGEM

Optimistic Buy Rating for Cullinan Management Driven by Promising CLN-049 Therapy Results

William Blair analyst Matt Phipps has maintained their bullish stance on CGEM stock, giving a Buy rating on...

1M ago

CGEM

Cullinan Therapeutics Presents Promising CLN-049 Data

Cullinan Management ( ($CGEM) ) has issued an announcement. On December 8, 2025, Cullinan Therapeutics presented updated clinical...

1M ago

CGEM

Cullinan Therapeutics shares updated clinical data from Phase 1 study of CLN-049

Cullinan Therapeutics (CGEM) shared updated clinical data from its Phase 1 study of CLN-049, a novel, investigational FLT3xCD3...

1M ago

CGEM

Cullinan Therapeutics receives FDA fast track designation for CLN-049

Cullinan Therapeutics (CGEM) announced that the U.S. Food and Drug Administration has granted Fast Track designation to CLN-049...

1M ago

CGEM

Buy Rating for Cullinan Therapeutics Driven by Promising AML Treatment Developments and Strong Market Potential

JonesTrading analyst Soumit Roy has reiterated their bullish stance on CGEM stock, giving a Buy rating on November...

1M ago

CGEM

CGEM FAQ

What was Cullinan Management’s price range in the past 12 months?

Cullinan Management lowest stock price was $5.68 and its highest was $13.33 in the past 12 months.

What is Cullinan Management’s market cap?

Cullinan Management’s market cap is $600.21M.

When is Cullinan Management’s upcoming earnings report date?

Cullinan Management’s upcoming earnings report date is Mar 05, 2026 which is in 54 days.

How were Cullinan Management’s earnings last quarter?

Cullinan Management released its earnings results on Nov 06, 2025. The company reported -$0.77 earnings per share for the quarter, beating the consensus estimate of -$0.947 by $0.177.

Is Cullinan Management overvalued?

According to Wall Street analysts Cullinan Management’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Cullinan Management pay dividends?

Cullinan Management does not currently pay dividends.

What is Cullinan Management’s EPS estimate?

Cullinan Management’s EPS estimate is -0.79.

How many shares outstanding does Cullinan Management have?

Cullinan Management has 59,076,260 shares outstanding.

What happened to Cullinan Management’s price movement after its last earnings report?

Cullinan Management reported an EPS of -$0.77 in its last earnings report, beating expectations of -$0.947. Following the earnings report the stock price went up 0.547%.

Which hedge fund is a major shareholder of Cullinan Management?

Currently, no hedge funds are holding shares in CGEM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Cullinan Management Stock Smart Score

Neutral

Fundamentals

Return on Equity

-40.18%

Trailing 12-Months

Asset Growth

-25.89%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Cullinan Management

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Cullinan Management (CGEM) Earnings & Revenues

Historic Earnings Reports

CGEM Stock 12 Month Forecast

Average Price Target

$31.71

▲(189.85% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","22":"$22","39":"$39","13.5":"$13.5","30.5":"$30.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$38.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31.71,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$31.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$24.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,13.5,22,30.5,39],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.75,12.846153846153847,14.942307692307693,17.03846153846154,19.134615384615387,21.230769230769234,23.326923076923077,25.423076923076923,27.51923076923077,29.615384615384617,31.711538461538463,33.80769230769231,35.90384615384615,{"y":38,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.75,12.362307692307692,13.974615384615385,15.586923076923078,17.19923076923077,18.81153846153846,20.423846153846156,22.036153846153848,23.64846153846154,25.26076923076923,26.873076923076923,28.485384615384618,30.09769230769231,{"y":31.71,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.75,11.76923076923077,12.788461538461538,13.807692307692307,14.826923076923077,15.846153846153847,16.865384615384613,17.884615384615383,18.903846153846153,19.923076923076923,20.942307692307693,21.96153846153846,22.98076923076923,{"y":24,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":15.78,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.18,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.56,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.49,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.52,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.75,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.64,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.67,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.49,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.66,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.75,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >